Skip to main content
SpringerLink
Log in

The Antibacterial-Corticosteroid Combination

What is its Role in Atopic Dermatitis?

  • Leading Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

The role of Staphylococcus aureus and therefore the place of combined antistaphylococcal and corticosteroid therapy in atopic dermatitis remains uncertain. While overt secondary infections such as furunculosis and impetigo respond rapidly to antibacterials, there is conflicting evidence as to the effect of antistaphylococcal therapy in atopic dermatitis that is not overtly infected. It is unlikely that antibacterials contribute to the management of mild atopic dermatitis. In more severe cases higher densities of S. aureus colonization are present. Antibacterials, whether topical or systemic, in combination with topical corticosteroids, may produce a more rapid decrease in S. aureus colonization than topical corticosteroids alone. Evidence for an accompanying greater speed in clinical improvement of the dermatitis is, however, mostly lacking.

Topical antibacterial-corticosteroid combinations can be useful when treating small areas of skin for a limited period of time but are accompanied by the risk of sensitization and the emergence of resistant strains of bacteria. Systemic antibacterials in combination with topical corticosteroid are more appropriate when larger areas are involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Table I

Similar content being viewed by others

References

  1. Leyden J.J., Marples R.R., Kligman A.M. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525–530

    Article  PubMed  CAS  Google Scholar 

  2. Williams R.E.A., Gibson A.G., Aitchison T.C., et al. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990; 123: 493–501

    Article  PubMed  CAS  Google Scholar 

  3. Bibel D.J., Aly R., Shinefield H.R., et al. The Staphylococcus aureus receptor for fibronectin. J Invest Dermatol 1983; 80: 494–496

    Article  PubMed  CAS  Google Scholar 

  4. Hay R.J., Adriaans B.M. Bacterial infections. In: Champion R.H., Burton J.L., Burns D.A., et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 1097–1179

    Google Scholar 

  5. Veien N.K. Antibiotics in bacterial skin infections. Br J Dermatol 1998; 139 Suppl. 53: 30–36

    Article  PubMed  Google Scholar 

  6. White M.I., Noble W.C. The cutaneous reaction to staphylococcal protein A in patients with atopic dermatitis or psoriasis. Br J Dermatol 1985; 113: 179–183

    Article  PubMed  CAS  Google Scholar 

  7. McFadden J.P., Noble W.C., Camp R.D.R. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631–632

    Article  PubMed  CAS  Google Scholar 

  8. Jappe U., Heuck D., Witte W., et al. Superantigen production by Staphylococcus aureus in atopic dermatitis: no more than a coincidence? [letter]. J Invest Dermatol 1998 May; 110 (5): 844–886

    Article  PubMed  CAS  Google Scholar 

  9. Zollner T.M., Kaufmann R. Superantigens in T cell mediated skin diseases — more than a coincidence [letter; comment]. J Invest Dermatol 1999 Jan; 112 (1): 118–119

    Article  PubMed  CAS  Google Scholar 

  10. Wachs G.N., Maibach H.I. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginised atopic dermatitis. Br J Dermatol 1976; 95: 323–328

    Article  PubMed  CAS  Google Scholar 

  11. Leyden J.J., Kligman A.M. The case for steroid-antibiotic combinations. Br J Dermatol 1977; 96: 179–187

    Article  PubMed  CAS  Google Scholar 

  12. Lever R., Hadley K., Downey D., et al. Staphylococcal colonisation in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189–198

    Article  PubMed  CAS  Google Scholar 

  13. Ramsay C.A., Savoie J.M., Gilbert M. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. J Eur Acad Dermatol Venereol 1996; 7 Suppl. 1: S15–S22

    Article  Google Scholar 

  14. Hjorth N., Schmidt H., Thomasen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica 1985; 4: 126–131

    PubMed  CAS  Google Scholar 

  15. Hill V.A., Wong E., Corbett M.F., et al. Comparative efficacy of betamethasone/clioquinol (Betnovate-C) cream and betamethasone/fusidic acid (Fucibet) cream in the treatment of infected hand eczema. J Dermatol Treatment 1998; 9: 15–19

    Article  CAS  Google Scholar 

  16. Poyner T.F., Dass B.K. Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin H cream) and miconazole/hydrocortisone cream (Daktacort cream) in infected eczema. J Eur Acad Dermatol Venereol 1996; 7 Suppl. 1: S23–S30

    Article  Google Scholar 

  17. Meenan F.O.C. A double-blind comparative study to compare the efficacy of Locoid C with Tri-Adcortyl in children with infected eczema. Br J Clin Pract 1988; 42: 200–202

    PubMed  CAS  Google Scholar 

  18. Jaffe G.V., Grimshaw J.J. A clinical trial of hydrocortisone/potassium hydroxyquinolone sulphate (Quinocort) in the treatment of infected eczema and impetigo in general practice. Pharmatherapeutica 1986; 4: 628–636

    PubMed  CAS  Google Scholar 

  19. Noble W.C. Skin bacteriology and the role of Staphylococcus aureus in infection. Br J Dermatol 1998; 139 Suppl. 53: 9–12

    Article  PubMed  Google Scholar 

  20. Ewing C.I., Ashcroft C., Gibbs A.C.C., et al. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998; 138: 1022–1029

    Article  PubMed  CAS  Google Scholar 

  21. Charman C. Clinical evidence: atopic eczema. BMJ 1999; 318: 1600–1604

    Article  PubMed  CAS  Google Scholar 

  22. White M.I., Noble W.C. Consequences of colonisation and infection by Staphylococcus aureus in atopic dermatitis. Clin Exp Dermatol 1986; 11: 34–40

    Article  PubMed  CAS  Google Scholar 

  23. Nilsson E.J., Henning C.G., Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29–34

    Article  PubMed  CAS  Google Scholar 

  24. Stadler J.F., Fleury M., Sourisse M., et al. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536–540

    Google Scholar 

  25. Slack R.C.B. Topical use of antimicrobial agents. In: Greenwood D., editor. Antimicrobial chemotherapy. Oxford: Oxford University Press, 1995; 387–394

    Google Scholar 

  26. Jackson D., Tasker T.C.G., Sutherland R., et al. Clinical pharmacology of Bactroban: pharmacokinetics, tolerance and efficacy studies. Curr Clin Pract 1985; 16: 54–67

    Google Scholar 

  27. Wilkinson J.D., Shaw S. Contact dermatitis: allergic. In: Champion R.H., Burton J.L., Burns D.A., et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 733–819

    Google Scholar 

  28. Wakelin S.H., Shaw S., Marren S., et al. Allergic contact dermatitis to newer topical anti-staphylococcal agents [abstract]. Br J Dermatol 1996; 135 Suppl. 47: 17

    Google Scholar 

  29. Smith R.J., Alder V.G., Warin R.P. Pyogenic cocci in infantile eczema throughout one year. BMJ 1975; 3: 199–201

    Article  PubMed  CAS  Google Scholar 

  30. Simpson-Dent S.L., Hunt S.J., Hardman C., et al. Rates of fusidic acid resistance in paediatric dermatology patients — a 6-year study. Br J Dermatol 2000; 143 Suppl. 57: 127

    Google Scholar 

  31. Ravenscroft J.C., Layton A., Murtagh M., et al. Study to assess the effect of short-term topical fusidic acid resistant (FusR) S. aureus in eczema patients. Br J Dermatol 2000; 143 Suppl. 57: 68–69

    Google Scholar 

  32. Chu T. Audit of new referrals with atopic dermatitis over a two month period. In: Hobbs F.D.R., editor. Managing Staphylococcus aureus in eczema. London: Royal Society of Medicine Press, 1999 (Round table Series 61): 7–14

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glan Clwyd Hospital, Bodelwyddan, Rhyl, Denbighshire, LL18 5UJ, Wales, UK

    Richard E. A. Williams

Authors
  1. Richard E. A. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, R.E.A. The Antibacterial-Corticosteroid Combination. Am J Clin Dermatol 1, 211–215 (2000). https://doi.org/10.2165/00128071-200001040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200001040-00002

Keywords

Search

Navigation